Cross-fund · 6 holders
REGN
REGENERON PHARMACEUTICALS
CUSIP 75886F107
6
Tracked holders
$14.49B
Aggregate value
18,762,204
Shares
6
Active funds
Funds holding REGN
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $7.00B | 0.10% | +26,884 | +0.3% |
| BlackRock | Institutional | Q1 2026 | $6.91B | 0.12% | +206,465 | +2.4% |
| Citadel | Multi-Strategy | Q1 2026 | $335.2M | 0.05% | −250,483 | −36.6% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $116.3M | 0.15% | −115,252 | −43.4% |
| Millennium | Multi-Strategy | Q1 2026 | $102.2M | 0.04% | −311,538 | −70.2% |
| BridgewaterFEAT | Macro | Q1 2026 | $17.6M | 0.08% | −50,021 | −68.8% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.